课题基金 / 基金详情

Generation and Characterization of Knockout Mice Targeting REV7 gene, which is involved in DNA damage tolerance

Generation and Characterization of Knockout Mice Targeting REV7 gene, which is involved in DNA damage tolerance
靶向 REV7 基因的敲除小鼠的生成和表征,该基因参与 DNA 损伤耐受
批准号:
17590340
负责人:
MURAKUMO Yoshiki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

MURAKUMO Yoshiki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the present study, we aimed to generate and analyze REV7 knockout mice. We carried out the construction of a knockout vector targeting the middle region of REV7, exon 3 to 6, in which REV7 interacts various proteins. The knockout vector was introduced into ES cells, and the cells were incubated in the selection medium with G418. About 150 G418-resistant colonies were cloned, and their genomic DNAs were extracted and used for PCR screening to identify homologous recombinants. However, we could not find homologous recombinants. Then we constructed another knockout vector using a different plasmid vector and introduced the vector into ES cells. About 750 G418-resistant clones were isolated and screened for identification of homologous recombinants. Despite many times of screening using various PCR condition, we could not find homologous recombinants in these clones. Possible reasons for the failure to identify homologous recombinants were ; 1) the genomic region cloned into the knockout vectors might not be suitable for homologous recombination, 2) PCR screening was not appropriate for identification of homologous recombinants in this case. For this reason, we decided to make the other knockout construct again using the different region of REV7 genome for homologous recombination. We constructed a new knockout vector targeting the region from exon 1 to exon 6 of REV7. We will introduce the new vector into ES cells soon and advance our project to generate REV7 knockout mice.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1365-2443.2006.00938.x
发表时间: 2006-03-01
期刊: GENES TO CELLS
影响因子: 2.1
作者: [Murakumo, Y, Mizutani, S, Takahashi, M]
通讯作者: Takahashi, M
DOI: 10.1111/j.1349-7006.2007.00457.x
发表时间: 2007-06-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Ishida, Maki, Ichihara, Masatoshi, Takahashi, Masahide]
通讯作者: Takahashi, Masahide
DOI: 10.1111/j.1440-1827.2005.01807.x
发表时间: 2005-04-01
期刊: PATHOLOGY INTERNATIONAL
影响因子: 2.2
作者: [Zhang, JM, Hashimoto, M, Takahashi, M]
通讯作者: Takahashi, M
Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
DNA 损伤检查点通路的组成部分调节染色体脆弱位点 FHIT 和 WWOX 基因表达的 UV 暴露依赖性改变。
DOI: --
发表时间: 2005
期刊: Mol Cancer Res 3(3)
影响因子: --
作者: [Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M, Furukawa Y.]
通讯作者: Furukawa Y.
9
    Significance of REV7 for germ cell maintenance and spermatogenesis
    • 批准号:
      24590479
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    Analyses of biological significance of GPI-anchored protein CD109 in mouse development
    • 批准号:
      21590435
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    Involvement of DNA repair protein REV7 in cell proliferation, mobility and organogenesis
    • 批准号:
      19590387
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    Characterization of human REV proteins which are involved in mutagenesis
    • 批准号:
      14570185
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2002
    • 负责人:
      MURAKUMO Yoshiki
    • 依托单位:
    国内基金
    海外基金
    REV7启动子表观遗传重塑调控卵巢癌化疗耐药的分子机制研究
    DNA损伤修复蛋白REV7在精子发生中的功能和分子机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      张丽虹
    • 依托单位:
    REV7通过跨损伤合成促进ALL耐药复发的作用机制研究
    • 批准号:
      82100179
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      杨定鹏
    • 依托单位:
    REV7在维持精原干细胞基因组稳定性中的作用机制研究
    • 批准号:
      82001610
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      乐威
    • 依托单位: